- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Global Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
439
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
439 companies
EZZ Life Science Holdings
Market Cap: AU$68.9m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.46
7D
0%
1Y
73.8%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$1.97
7D
13.2%
1Y
111.8%
Kiora Pharmaceuticals
Market Cap: US$8.0m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases in the United States.
KPRX
US$2.66
7D
1.3%
1Y
-48.6%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥10.0b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.34
7D
-7.7%
1Y
-10.0%
Rhone Ma Holdings Berhad
Market Cap: RM 138.3m
An investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia.
RHONEMA
RM 0.63
7D
0.8%
1Y
-6.0%
Hyphens Pharma International
Market Cap: S$83.4m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.27
7D
-3.6%
1Y
0%
Pak Fah Yeow International
Market Cap: HK$707.4m
An investment holding, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.27
7D
1.8%
1Y
10.2%
NeuroScientific Biopharmaceuticals
Market Cap: AU$5.1m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.035
7D
-2.8%
1Y
-41.7%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.13
7D
-5.0%
1Y
-5.8%
Kotra Industries Berhad
Market Cap: RM 585.8m
An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.
KOTRA
RM 3.95
7D
-1.3%
1Y
-16.0%
SSY Group
Market Cap: HK$9.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.04
7D
-10.6%
1Y
-38.0%
Biovica International
Market Cap: SEK 68.5m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.70
7D
-18.6%
1Y
-69.6%
Uni-Bio Science Group
Market Cap: HK$400.1m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.067
7D
-2.9%
1Y
-22.1%
Futura Medical
Market Cap: UK£30.1m
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
FUM
UK£0.099
7D
3.2%
1Y
-72.7%
Little Green Pharma
Market Cap: AU$36.3m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.12
7D
0%
1Y
-14.3%
Newbury Pharmaceuticals
Market Cap: SEK 81.3m
Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.
NEWBRY
SEK 3.35
7D
5.0%
1Y
-2.3%
Arterra Bioscience
Market Cap: €14.2m
A research-based biotech company, engages in the research and development of various ingredients and natural solutions.
ARBS
€2.14
7D
-0.9%
1Y
9.7%
Puma Biotechnology
Market Cap: US$139.9m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$2.82
7D
-2.8%
1Y
-46.5%
Elicera Therapeutics
Market Cap: SEK 148.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 3.06
7D
4.8%
1Y
150.8%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$941.2m
Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.
8049
HK$1.68
7D
0%
1Y
-4.0%
Medical Developments International
Market Cap: AU$56.3m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.50
7D
-3.8%
1Y
-14.5%
Cabaletta Bio
Market Cap: US$62.4m
A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.
CABA
US$1.23
7D
10.8%
1Y
-92.8%
Diaceutics
Market Cap: UK£95.1m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
DXRX
UK£1.13
7D
0%
1Y
8.2%
Aroa Biosurgery
Market Cap: AU$134.5m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.39
7D
-6.0%
1Y
-31.0%
Citius Pharmaceuticals
Market Cap: US$8.1m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.94
7D
-7.4%
1Y
-95.2%
CureVac
Market Cap: US$715.6m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC
US$3.19
7D
23.2%
1Y
9.6%
Protalix BioTherapeutics
Market Cap: US$188.1m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.41
7D
0.8%
1Y
104.2%
Genetic Signatures
Market Cap: AU$85.2m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.38
7D
-24.2%
1Y
-45.7%
Apex Healthcare Berhad
Market Cap: RM 1.4b
An investment holding company, engages in the development, manufacture, marketing, distribution, and wholesaling of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.
AHEALTH
RM 2.01
7D
-5.2%
1Y
-33.9%
Decibel Cannabis
Market Cap: CA$31.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.055
7D
0%
1Y
-60.7%
Planet 13 Holdings
Market Cap: CA$110.6m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.34
7D
36.0%
1Y
-64.2%
Vanda Pharmaceuticals
Market Cap: US$240.8m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.13
7D
-0.2%
1Y
0.2%
Lee's Pharmaceutical Holdings
Market Cap: HK$718.4m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.22
7D
-12.9%
1Y
3.4%
Evoke Pharma
Market Cap: US$4.6m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$2.20
7D
-2.2%
1Y
-64.1%
Vita Life Sciences
Market Cap: AU$100.4m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$1.81
7D
-2.2%
1Y
-21.6%
aTyr Pharma
Market Cap: US$263.9m
A biotherapeutics company, engages in the discovery and development of medicines based on novel functions of tRNA synthetases in the United States.
ATYR
US$2.97
7D
13.4%
1Y
70.7%